Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN

Alessandro Andriani,Marco Montanaro,Maria Teresa Voso,Nicoletta Villivà,Fabrizio Ciccone,Cristina Andrizzi,Cinzia De Gregoris,Ambra Di Veroli,Luca Maurillo,Giuliana Alimena,Roberto Latagliata

Leukemia Research（2015）

引用 24|浏览27

暂无评分

摘要

•Azacytidine is active in patients with blastic evolution of MPN (complete response 26.3%).•The treatment is safe with an acceptable hematologic and extra-hematologic toxicity.•The overall survival of AZA patients is improved compared to historical controls.

查看译文

关键词

MPN,Blastic phase,Azacytidine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要